-+ 0.00%
-+ 0.00%
-+ 0.00%

XENTRIA: PROPOSED AMENDMENT TO XTMAB-16-201 PART B TO EVALUATE 4MG/KG EVERY FOUR WEEKS IN A 52-WEEK EFFICACY STUDY CALLED XATLAS STUDY

Reuters·09/01/2026 11:01:25

Please log in to view news